Efficacy of Gamification in Enhancing User Engagement

Not Applicable

Completed

Brief Summary: As part of Phase II of the NIH SBIR grant, the study will conduct a randomized controlled clinical trial in which the MapHabit system's gamification is investigated to determine whether the assistive technology facilitates user engagement and retention. Additionally, the study will examine if the gamified software improves the quality of life of persons with dementia and reduce the burden of the respective care partners. Participants will be individuals with Alzheimer's disease or related dementias in mild to moderate stage of cognitive impairment, accompanied by their respective primary care partner (i.e., primary familial caregiver). The study will be a randomized controlled clinical trial, in which two conditions will be investigated: 1) experimental condition in which MHS+Gamification is implemented into the daily care received by participants 2) control condition in which the MHS alone and separate engagement material is incorporated into the participant's daily care. Sample size goal will strive for a total of 40 individual-caregiver dyads, 20 in each condition. The study duration will be a 6-month intervention.

Recruitment & Eligibility

Inclusion Criteria

Individual diagnosed with Alzheimer's disease or other related dementia (ADRD) in their mild to moderate stage of impairment
Participating caregiver of individual with dementia must be the primary caregiver
Proficient in English

Exclusion Criteria

Individual not diagnosed with ADRD
Participating caregiver of individual with dementia is NOT the primary caregiver
Not proficient in English

Primary Outcome Measures

Name	Time	Method
Change in User Interaction and Engagement From Baseline to 6 Months	User engagement (i.e., map count) was collected daily for the total duration of 180 days/6 months of the subject's participation. Usage data was segmented and analyzed via monthly basis.	Our internal analytics of the software can assess the user's interactions with the application by tracking user's map use count per month. By combining these data points, we can determine the average engagement for each participant and compare them between groups.
Quality of Life-18 (QoL-18)	The instrument was administered to the participants once -- at the end of their participation in the 6 month study.	18-item quality-of-life questionnaire (QoL-18) evaluated a range of participants' behaviors, including mood, engagement, and memory at the end of the study compared to before the use of the MHS. The instrument is scored on a Likert Scale, ranging from 1-5. A higher number indicates better outcome.

Secondary Outcome Measures

Name	Time	Method
2-item Satisfaction Scale (SS-2)	The instrument was administered to the participants after the completion of the study duration (i.e., assessed at 6 months)	Quantifies participant's endorsements to two survey questions: How satisfied were they with the MHS? How much progress did they feel like they made? Both questions are scored on a 10-point scale, with a higher value reflecting a better outcome/experience.